Lyka Labs Limited - Asset Resilience Ratio

Latest as of September 2025: 0.01%

Lyka Labs Limited (LYKALABS) has an Asset Resilience Ratio of 0.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Lyka Labs Limited PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs250.00K
≈ $2.70K USD Cash + Short-term Investments

Total Assets

Rs1.68 Billion
≈ $18.15 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Lyka Labs Limited's Asset Resilience Ratio has changed over time. See net asset quality index of Lyka Labs Limited to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Lyka Labs Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Lyka Labs Limited worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs250.00K 0.01%
Total Liquid Assets Rs250.00K 0.01%

Asset Resilience Insights

  • Limited Liquidity: Lyka Labs Limited maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Lyka Labs Limited Industry Peers by Asset Resilience Ratio

Compare Lyka Labs Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Spyre Therapeutics Inc.
NASDAQ:SYRE
Biotechnology 84.34%
3SBio Inc
F:83B
Biotechnology 10.64%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
Biotechnology 0.02%
Novavax Inc
NASDAQ:NVAX
Biotechnology 53.87%
BB Biotech AG
SW:BION
Biotechnology 0.05%

Annual Asset Resilience Ratio for Lyka Labs Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Lyka Labs Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.01% Rs193.00K
≈ $2.09K
Rs1.76 Billion
≈ $19.06 Million
-3.63pp
2024-03-31 3.64% Rs57.09 Million
≈ $617.39K
Rs1.57 Billion
≈ $16.95 Million
-4.09pp
2023-03-31 7.73% Rs117.19 Million
≈ $1.27 Million
Rs1.52 Billion
≈ $16.39 Million
-1.89pp
2022-03-31 9.62% Rs178.62 Million
≈ $1.93 Million
Rs1.86 Billion
≈ $20.07 Million
+5.85pp
2021-03-31 3.77% Rs71.61 Million
≈ $774.47K
Rs1.90 Billion
≈ $20.55 Million
-1.38pp
2020-03-31 5.15% Rs103.09 Million
≈ $1.11 Million
Rs2.00 Billion
≈ $21.65 Million
+2.98pp
2019-03-31 2.17% Rs47.11 Million
≈ $509.47K
Rs2.17 Billion
≈ $23.51 Million
+0.52pp
2018-03-31 1.65% Rs38.75 Million
≈ $419.07K
Rs2.35 Billion
≈ $25.42 Million
-1.27pp
2017-03-31 2.92% Rs72.59 Million
≈ $785.02K
Rs2.48 Billion
≈ $26.87 Million
+1.19pp
2013-03-31 1.74% Rs50.15 Million
≈ $542.40K
Rs2.89 Billion
≈ $31.24 Million
+1.73pp
2012-03-31 0.00% Rs100.00K
≈ $1.08K
Rs2.83 Billion
≈ $30.55 Million
-0.82pp
2008-03-31 0.82% Rs15.17 Million
≈ $164.01K
Rs1.84 Billion
≈ $19.93 Million
+0.23pp
2007-03-31 0.60% Rs9.53 Million
≈ $103.01K
Rs1.60 Billion
≈ $17.27 Million
-3.44pp
2005-03-31 4.03% Rs56.62 Million
≈ $612.33K
Rs1.40 Billion
≈ $15.18 Million
--
pp = percentage points

About Lyka Labs Limited

NSE:LYKALABS India Biotechnology
Market Cap
$27.04 Million
Rs2.50 Billion INR
Market Cap Rank
#24155 Global
#1331 in India
Share Price
Rs70.06
Change (1 day)
-0.64%
52-Week Range
Rs44.95 - Rs116.18
All Time High
Rs254.30
About

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-d… Read more